← Back to directory
Richard Piekarz
Researcher Next ID · RN-013754
Researcher · Biochemistry, Genetics and Molecular Biology
, Ukraine
Not currently recruitingFunding unknown
- Works count
- 366
- Citation count
- 7,829
- H-index
- 44
- i10-index
- 96
Research interests
Biochemistry, Genetics and Molecular Biology
Medicine
Histone Deacetylase Inhibitors Research
Epigenetics and DNA Methylation
Protein Degradation and Inhibitors
Peptidase Inhibition and Analysis
PARP inhibition in cancer therapy
Publications
Phase 2 trial of romidepsin in patients with peripheral T-cell lymphoma
Blood · 2011 · 10.1182/blood-2010-10-312603
Phase II Multi-Institutional Trial of the Histone Deacetylase Inhibitor Romidepsin As Monotherapy for Patients With Cutaneous T-Cell Lymphoma
Journal of Clinical Oncology · 2009 · 10.1200/jco.2008.21.6150
Phase I trial of the histone deacetylase inhibitor, depsipeptide (FR901228, NSC 630176), in patients with refractory neoplasms.
PubMed · 2002
Inhibitor of histone deacetylation, depsipeptide (FR901228), in the treatment of peripheral and cutaneous T-cell lymphoma: a case report
Blood · 2001 · 10.1182/blood.v98.9.2865
Current projects
No projects listed.